Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects Meeting Abstract


Authors: Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; Hamlin, P.; Lichtman, S. M.; Matasar, M. J.; Portlock, C. S.; Shukla, N.; Wasserheit-Lieblich, C.; Zelenetz, A. D.; Gerecitano, J. F.
Abstract Title: Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349242703216
PROVIDER: wos
Notes: Meeting Abstract: 3487 -- Source: Wos
MSK Authors
  1. Zhigang Zhang
    272 Zhang
  2. Carol Portlock
    198 Portlock
  3. Robert Motzer
    909 Motzer
  4. Craig Moskowitz
    388 Moskowitz
  5. Sergio Andres Giralt
    610 Giralt
  6. Stuart Lichtman
    191 Lichtman
  7. Hani Hassoun
    168 Hassoun
  8. Andrew D Zelenetz
    599 Zelenetz
  9. Heather Jolie Landau
    215 Landau
  10. Nikoletta Lendvai
    97 Lendvai
  11. Paul Hamlin
    186 Hamlin
  12. Matthew J Matasar
    149 Matasar
  13. Philip C Caron
    41 Caron
  14. Neerav Shukla
    86 Shukla
  15. Connie Wing-Ching Lee
    69 Lee
  16. Karuna   Ganesh
    22 Ganesh